SCHEMBL2054820

SCHEMBL2054820

CC(=O)Nc1nc2c(ncn2C(C)=O)c(=O)[nH]1

nearest known ligand 0.57

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.57
TSHR P16473 1/20 0.57
KMT2A Q03164 1/20 0.57
KDM4E B2RXH2 1/20 0.51
GAA P10253 1/20 0.51
TAS1R3 Q7RTX0 1/20 0.48
TAS1R1 Q7RTX1 1/20 0.48
GDA Q9Y2T3 1/20 0.47
ADORA3 P0DMS8 1/20 0.40
FGFR1 P11362 2/20 0.40
FGFR2 P21802 2/20 0.40
ALDH1A1 P00352 2/20 0.40
POLB P06746 1/20 0.40
ALOX15 P16050 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
LMNA P02545 1/20 0.38
TK1 P04183 1/20 0.37
HPGD P15428 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9581455 0.87 MEN1 (0.53) MEN1TSHRKMT2AKDM4EGAA
SCHEMBL22091499 0.87 KDM4E (0.47) MEN1TSHRKMT2AKDM4EGAA
SCHEMBL27929251 0.84 MEN1 (0.58) MEN1TSHRKMT2AKDM4EGAA
SCHEMBL24767728 0.81 MEN1 (0.55) MEN1TSHRKMT2AKDM4EGAA
SCHEMBL25964378 0.81 MEN1 (0.55) MEN1TSHRKMT2AKDM4EGAA
SCHEMBL218668 0.78 XDH (0.53) MEN1TSHRKMT2AALDH1A1LMNA
SCHEMBL28942682 0.77 TSHR (0.65) MEN1TSHRKMT2AKDM4EGAA
SCHEMBL21011225 0.76 KMT2A (0.53) MEN1TSHRKMT2AKDM4EGAA
SCHEMBL29154439 0.75 MEN1 (0.60) MEN1TSHRKMT2AKDM4EGAA
SCHEMBL8165625 0.75 PNP (0.62) MEN1TSHRKMT2AALDH1A1TK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118084913-A Synthesis and refining method of monochloroganciclovir condensate 上药康丽(常州)药业有限公司 2024-05-28 CN claimed
CN-117486904-A Synthesis and refining method of ganciclovir impurity 上药康丽(常州)药业有限公司 2024-02-02 CN claimed
CN-115367745-B Tungsten-containing substance hybridization and nitrogen-doped porous carbon material and preparation method thereof 北京化工大学 2023-11-24 CN claimed
CN-115367726-A Oxygen-doped titanium nitride hybridized and nitrogen-doped porous carbon material and preparation method and application thereof 北京化工大学 2022-11-22 CN claimed
CN-115367745-A Tungsten-containing substance hybrid and nitrogen-doped porous carbon material and preparation method thereof 北京化工大学 2022-11-22 CN claimed
WO-1997011944-A1 IMPROVED PROCESS FOR PRODUCING 9-(2-HYDROXYETHOXY)-METHYLGUANINE (ACYCLOVIR) BOEHRINGER INGELHEIM KG (DE) 1997-04-03 WO claimed
US-20240384343-A1 GRAPHENE OXIDE-BASED FLUORESCENT SENSOR FOR BIOMOLECULAR DETECTION CITY UNIVERSITY OF HONG KONG (HK) 2024-11-21 US disclosed
CN-221445833-U Diacetyl guanine concentration detector 通辽德胜生物科技有限公司 2024-07-30 CN disclosed
CN-118084913-A Synthesis and refining method of monochloroganciclovir condensate 上药康丽(常州)药业有限公司 2024-05-28 CN disclosed
CN-118084913-A Synthesis and refining method of monochloroganciclovir condensate 上药康丽(常州)药业有限公司 2024-05-28 CN disclosed
CN-117486904-A Synthesis and refining method of ganciclovir impurity 上药康丽(常州)药业有限公司 2024-02-02 CN disclosed
CN-117486904-A Synthesis and refining method of ganciclovir impurity 上药康丽(常州)药业有限公司 2024-02-02 CN disclosed
CN-115367745-B Tungsten-containing substance hybridization and nitrogen-doped porous carbon material and preparation method thereof 北京化工大学 2023-11-24 CN disclosed
EP-0717744-B1 A PROCESS FOR THE PREPARATION OF 9-(2-HYDROXY)-ETHOXYMETHYL-GUANINE RECORDATI CHEM PHARM (CH) 1997-05-07 EP disclosed
WO-1997011944-A1 IMPROVED PROCESS FOR PRODUCING 9-(2-HYDROXYETHOXY)-METHYLGUANINE (ACYCLOVIR) BOEHRINGER INGELHEIM KG (DE) 1997-04-03 WO disclosed
EP-0452680-B1 Substituted purines, process for their preparation and their use as antiviral agents HOECHST AG (DE) 1996-11-06 EP disclosed
US-5434263-A Process for the preparation of 2-acylamino-6-halopurine from 2,9-diacylguanine HOECHST AKTIENGESELLSCHAFT (DE) 1995-07-18 US disclosed
EP-0452680-A1 Substituted purines, process for their preparation and their use as antiviral agents HOECHST AKTIENGESELLSCHAFT (DE) 1991-10-23 EP disclosed
EP-0433846-A1 Process for the preparation of 2-acylamino-6-halogeno-purine from 2,9-diacylguanine HOECHST AKTIENGESELLSCHAFT (DE) 1991-06-26 EP disclosed
EP-0105486-A2 1-Monophosphate esters, 1,3-bisphosphate esters and cyclic phosphate esters of 9-(1,3-dihydroxy-2-propoxymethyl)-guanine as antiviral agents SYNTEX (U.S.A.) INC. (US) 1984-04-18 EP disclosed